ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0

NCT01539629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-12-05

No results posted yet for this study

Summary

This 3rd phase of the ELEVATE study. The study is collecting data from an implanted CRT-D device to evaluate a new feature for future heart failure devices.

Conditions

Interventions

DEVICE

Cardiac pacing

Cadiac pacing via a pulse generator and implaned intracardiac leads.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Kenneth L Ellenbogen, MD · Virginia Commonwealth University Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-06-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01539629 on ClinicalTrials.gov